Wave Life Sciences Ltd — holders 31-DEC-2025

Wave Life Sciences is a clinical-stage biotechnology company developing RNA-targeting and RNA-editing genetic medicines for neurological and other diseases.

Aggregate 13FScore 60 — mean of 2 scored holder(s) · buyers (new/add) avg 60. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Darwin Global Management, Ltd. (auto-surfaced)	38	New buy	7,298,421	$125,167,920	2.5%
Stanley Druckenmiller / Duquesne	81	New buy	173,000	$2,941	0.1%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

Filed	Form	Activist	% of class	Conviction
2026-04-17	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	17.1%	High	filing
2026-03-30	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	17.5%	High	filing

Insider open-market buys daily digest →

Filed	Insider	Role	Shares	Value
2026-03-30	RA CAPITAL MANAGEMENT, L.P.	director+10%-owner	8,772,496	$54,624,378	Form 4

Citrini Research coverage report library →

Report	Date	Stance
#80 — Market Memo: January Musings	2025-01-09	LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.